When IMiDs compete with cereblon for binding to the CD147-MCT1 complex, destabilization of the complex occurs, which inhibits its ability to promote tumor survival [69,80], as well as tumor cell growth and metabolism [62,69]. This evidence concerns the gene BSG and neoplasm.